Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-28 @ 7:54 AM
Study NCT ID:
NCT00389532
Status:
COMPLETED
Last Update Posted:
2016-04-14
First Post:
2006-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
None
Primary Completion Date:
2008-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-18
First Submit QC Date:
None
Study First Post Date:
2006-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-02-24
Results First Submit QC Date:
None
Results First Post Date:
2009-03-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-04-12
Last Update Post Date:
2016-04-14
Last Update Post Date Type:
ESTIMATED